D-Wave Quantum: A Government Cheque, a Nature Paper, and a Share Price That Refuses to Celebrate

D-Wave secures up to $100M under the CHIPS Act with a minority government stake, but shares stay weak as revenue lags bookings.

Washington has just handed D-Wave Quantum a validation that most early-stage technology companies can only dream of — and the market's response has been a shrug. Under an agreement with the US Department of Commerce, the company stands to receive up to $100 million from the CHIPS and Science Act, with the government taking a minority stake carrying no control rights. The stock, meanwhile, sits at EUR 14.39, down 2.3% from the previous session.

That disconnect raises a question that stretches well beyond one company: what is state backing actually worth in a young technology when investors are preoccupied with other concerns?

Three Deals, One Industrial Policy Signal

D-Wave is not alone in this arrangement. Rigetti Computing and Quantinuum each struck their own $100 million agreements with the Commerce Department, all three structured with a government minority holding. Read together, the trio looks less like a wager on any single player and more like a deliberate industrial-policy push behind quantum computing as a sector.

The money comes with strings attached. Further tranches are released only as D-Wave hits milestones covering installation, manufacturing, process integration and calibration. The company has earmarked the funding for two development tracks: an annealing system scaled to 100,000 qubits and a gate-model system at 10,000 qubits, feeding a roadmap that targets 100 logical qubits and more than one million operations by 2032.

Those are ambitions, not achievements — and that gap between political endorsement and operating reality is precisely what the capital market appears to be pricing.

The Science Behind the Subsidy

Strip away the policy headlines and there is a harder foundation underneath. In early August, D-Wave published peer-reviewed results in Nature describing a fast, high-precision two-qubit gate for its superconducting dual-rail architecture within the gate model. Fidelity came in at roughly 99.9%, with operation times of about 500 nanoseconds. Simulations suggest the dual-rail design could cut logical error rates by as much as a factor of ten with each error-correction step.

Three days before that publication, the company had announced a collaboration with Nasdaq Verafin to explore quantum computing as a tool for detecting financial crime. Taken together, the two announcements sketch a dual identity — basic researcher and commercial partner — that few peers in the sector pursue as consistently.

The sequencing matters. Without credible physics like the Nature work, it would be difficult to justify why a government agency would take equity in a still-lossmaking enterprise at all.

A CFO Exit Lands in the Middle of the News Flow

The federal funding has arrived alongside a change at the top of the finance function. Roughly a week before the CHIPS agreement was sealed, CFO John Markovich retired, with Greg Golkov stepping in on an interim basis. Management stressed there had been no disagreements behind the departure.

The market has not been generous since. The shares fell about 16.6% in the week through 28 August 2026, and over the past 30 days they have shed 18%. That weakness sits on top of a longer slide: the stock trades more than 64% below its 12-month high of EUR 40.41 set on 15 October, though it remains 32% above its 30 March low. Year to date it is down 35%, while the trailing twelve-month picture shows a gain of 7.4% — a reminder of just how violent the swings in this sector can be.

Bookings Boom, Revenue Doesn't Follow

The operating numbers, released more than a month ago, explain part of the tension. Second-quarter 2026 revenue came in at $3.1 million, essentially flat year over year, with commercial customers accounting for 62.4% of the total and Forbes Global 2000 companies contributing 47.7%. The QCaaS subscription business grew 50% to $1.9 million.

Bookings tell a more dramatic story — and a more misleading one. They rose 59% in the quarter to $2.1 million and surged 1,120% in the first half to $35.5 million, lifted by a single system sale worth more than $20 million. First-half revenue, by contrast, dropped 67% to $5.9 million, because a large system sale from 2025 no longer served as a comparable base.

That divergence between exploding orders and shrinking recurring revenue captures the pattern across much of quantum computing: individual contracts distort the statistics, and a dependable revenue stream has yet to materialise. Since those quarterly figures landed, the stock has lost a further 8.8% — evidence that even triple-digit percentage growth off a very small base fails to convince when the absolute amounts stay modest.

Institutions Step In as Analysts Step Back

Not everyone is reading the weakness as a warning. The Manufacturers Life Insurance Company reportedly acquired roughly 204,727 shares in early September, a position valued at about $4.9 million. Wellington Management Group also added to its holding in the most recent disclosure filings. Institutional buying into a falling market is no automatic buy signal, but it does show that some large investors see something other than deterioration.

The sell side has moved the other way. On 21 August, analysts at Zacks Research downgraded the stock from "Strong Buy" to "Hold" — a caution worth weighing against an annualised volatility of 78%, without dismissing the underlying technology.

What remains is the tension that defines the entire young quantum industry. The state distributes grants with the air of an industrial-policy architect, technical goals are expressed in qubit counts and operation rates that mean little to most investors, and the market keeps asking for revenue, profitability and a settled leadership team. D-Wave sits squarely at that fracture between a publicly funded future and the sober present of a company still at the very start of its commercial journey.

Whether today's millions in federal support eventually grow into billion-dollar markets is a bet on a technology — not on a quarterly earnings report. The next instalment of that answer arrives with the quarterly results due on 2 November.